# Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

> **NCT06884748** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 30 (estimated)

## Conditions studied

- Clostridioides Difficile Infection

## Interventions

- **DRUG:** Ursodiol 500 MG

## Key facts

- **NCT ID:** NCT06884748
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06884748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06884748, "Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06884748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*